Which side effect is uniquely associated with Ticagrelor therapy and may lead to drug discontinuation?
Show answer and explanation
Correct answer: Reversible dyspnea
Dyspnea (shortness of breath) is a known side effect of Ticagrelor, occurring in about 10-15% of patients. It is thought to be related to the drug's inhibition of adenosine reuptake, leading to increased systemic adenosine levels.
Keep practicing
More Antiplatelet Drugs questions
- What is the rationale for using 'Dual Antiplatelet Therapy' (DAPT) in patients following coronary stent placement?
- Which of the following agents is a synthetic heptapeptide that reversibly inhibits the Glycoprotein IIb/IIIa receptor?
- How long before an elective surgery should Aspirin typically be discontinued to allow for the restoration of normal platelet function?
- Cilostazol is primarily indicated for the treatment of which condition?
- Which antiplatelet drug can cause a rare but serious side effect known as Thrombotic Thrombocytopenic Purpura (TTP)?
- What is the primary effect of Thromboxane A2 (TXA2) on blood vessels?